V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260014751 | 260010135 | 1.56 | null | Palliative (P) | 2017-12-21 | 2018-03-11 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | N | 260016443 | TRASTUZUMAB |
| 260014752 | 260010136 | null | 80.6 | Curative (C) | 2017-12-08 | 2017-12-13 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | 2 | N | 260016530 | IPO |
| 260014753 | 260010138 | 1.69 | 86 | Not known (9) | 2017-12-27 | 2018-01-05 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 260016778 | CARBOPLATIN + ETOPOSIDE |
| 260014754 | 260014804 | 1.63 | 92.2 | Disease modification (D) | 2014-12-28 | 2014-12-28 | CYCLOPHOSPHAMIDE + VINORELBINE | 2 | N | 260016927 | CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 260014755 | 260010141 | 1.67 | 79 | Neo-adjuvant (N) | 2016-11-20 | 2016-12-04 | BLEOMYCIN | N | null | 260017081 | GEMCITABINE + OXALIPLATIN + PACLITAXEL |
| 260014756 | 260010142 | 1.74 | 69.3 | Disease modification (D) | 2017-01-09 | 2017-01-11 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260017081 | CARBOPLATIN + THIOTEPA + TOPOTECAN |
| 260014757 | 260010143 | 1.65 | 86 | null | 2017-07-16 | 2017-07-16 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 2 | N | 260017753 | IVA |
| 260014758 | 260014806 | 1.81 | 99 | null | 2015-04-12 | 2015-04-12 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 02 | N | 260017849 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260014759 | 260010146 | 1.8 | 83.1 | Palliative (P) | 2017-08-05 | 2017-08-07 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 260017935 | VINBLASTINE |
| 260014760 | 260010147 | 1.64 | 66.8 | Adjuvant (A) | 2018-11-03 | 2019-02-23 | NIVOLUMAB | N | N | 260017955 | NIVOLUMAB |
| 260014761 | 260010149 | 1.83 | 85.1 | Not known (9) | null | 2018-01-02 | Cisplatin + Vinorelbine (IV) | N | N | 260017955 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 260014762 | 260010149 | null | 65.6 | Palliative (P) | 2015-03-30 | 2015-11-22 | Cisplatin 7 day | 02 | N | 260017955 | CARBOPLATIN + PACLITAXEL |
| 260014763 | 260010150 | 1.76 | 71.4 | Curative (C) | null | 2018-10-25 | CARBO + THIOTEPA + TOPOTECAN | N | null | 260018283 | VINBLASTINE |
| 260014764 | 260010151 | 1.61 | 77.7 | Curative (C) | 2019-05-30 | 2019-09-15 | CISPLATIN + GEMCITABINE + RITUXIMAB | 02 | N | 260018301 | CVP |
| 260014765 | 260010152 | 1.58 | 90.6 | Curative (C) | 2015-02-12 | 2015-06-05 | CVP | N | N | 260018350 | CHOP |
| 260014766 | 260010154 | 1.68 | null | Disease modification (D) | 2018-08-16 | 2018-08-16 | CYCLO + RITUXIMAB + VINCRISTINE | 2 | N | 260018409 | CYCLOPHOSPHAMIDE |
| 260014767 | 260010156 | 1.72 | 91.8 | null | null | 2018-10-07 | BLEOMYCIN | null | null | 260018452 | BLEOMYCIN + VINCRISTINE |
| 260014768 | 260010157 | 1.56 | null | Curative (C) | 2019-01-18 | 2019-02-13 | FEC 60 or 75 | N | N | 260018483 | IBRUTINIB |
| 260014769 | 260010158 | null | 61.7 | Adjuvant (A) | 2017-11-30 | 2017-12-15 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 02 | N | 260018575 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + PACLITAXEL |
| 260014770 | 260010159 | 1.65 | 81 | Adjuvant (A) | 2017-02-03 | 2017-02-09 | CISPLATIN + ETOPOSIDE + PACLITAXEL | N | N | 260018853 | DOCETAXEL |
| 260014771 | 260010160 | 1.91 | 68.2 | null | 2018-12-04 | 2018-12-10 | R Chlorambucil | 02 | N | 260018918 | IFOSFAMIDE + PACLITAXEL |
| 260014772 | 260010161 | null | null | Curative (C) | 2018-06-29 | 2018-07-04 | CARBOPLATIN + ETOPOSIDE | N | N | 260018930 | CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 260014773 | 260010162 | 1.71 | 69 | Curative (C) | 2016-11-10 | 2016-11-13 | GEMCITABINE + TIP | N | N | 260019024 | MAP |
| 260014774 | 260010164 | 1.82 | 68.8 | Neo-adjuvant (N) | 2017-01-20 | 2017-03-21 | Erlotinib | 02 | N | 260019243 | BLEOMYCIN |
| 260014775 | 260014811 | 1.58 | 93.5 | Curative (C) | 2016-10-04 | 2017-05-30 | BLEOMYCIN + VINCRISTINE | N | N | 260019247 | CISPLATIN + EPIRUBICIN |
| 260014776 | 260019121 | null | null | Curative (C) | 2016-12-07 | 2017-05-12 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 02 | null | 260019247 | VEIP |
| 260014777 | 260010165 | 1.63 | 71.7 | Curative (C) | 2018-08-05 | 2018-08-10 | ICE | 02 | N | 260019284 | METHOTREXATE |
| 260014778 | 260010165 | 1.78 | 90 | Curative (C) | 2019-02-08 | 2019-03-18 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 260019284 | CYTARABINE HD + METHOTREXATE HD |
| 260014779 | 260010168 | 1.65 | 72 | Curative (C) | 2017-09-19 | 2017-09-19 | ICE + GCSF | N | N | 260019489 | DOCETAXEL |
| 260014780 | 260010169 | 1.65 | 81.2 | Curative (C) | null | 2015-03-11 | VIP | N | N | 260019623 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260014781 | 260010170 | 1.68 | 73.4 | Palliative (P) | 2015-11-21 | 2016-01-16 | STS Rhabdomyosarcoma RMS 2005 VA | N | N | 260019645 | PEMETREXED |
| 260014782 | 260019267 | 1.54 | 68.2 | Disease modification (D) | 2016-10-21 | 2016-10-21 | Cisplatin + Radiotherapy | 02 | N | 260019690 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260014783 | 260010172 | 1.69 | 59.5 | Adjuvant (A) | 2014-05-17 | 2014-05-17 | VIP | N | N | 260019700 | EP |
| 260014784 | 260010173 | 1.45 | 68.6 | Palliative (P) | 2019-06-02 | 2019-06-03 | Bendamustine + Obinutuzumab | N | N | 260019716 | DOCETAXEL + TRASTUZUMAB |
| 260014785 | 260010174 | 1.7 | 93 | Palliative (P) | 2017-06-06 | 2017-06-06 | Gemcitabine + Oxaliplatin | 02 | N | 260019770 | GEMCITABINE + OXALIPLATIN |
| 260014786 | 260010174 | 1.59 | 60.2 | Curative (C) | 2018-08-06 | 2018-09-10 | DOCETAXEL + TRASTUZUMAB | N | null | 260019770 | CISPLATIN + VINORELBINE + RT |
| 260014787 | 260010175 | 1.78 | 115 | Curative (C) | 2017-11-12 | 2017-11-20 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 02 | N | 260019996 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260014788 | 260010175 | 1.8 | 102.3 | Curative (C) | 2013-10-23 | 2013-10-24 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 02 | N | 260019996 | CARBOPLATIN + RT |
| 260014789 | 260010177 | null | null | Curative (C) | 2016-09-24 | 2017-01-16 | Pemetrexed | 2 | N | 260020256 | CYTARABINE HD + METHOTREXATE HD |
| 260014790 | 260010178 | 1.9 | 62.5 | Palliative (P) | 2017-06-13 | 2017-07-14 | POMB | N | N | 260020285 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 260014791 | 260017115 | 1.53 | 57.1 | Palliative (P) | 2018-03-29 | 2018-04-03 | Docetaxel + Trastuzumab (Maint) | N | N | 260020285 | CVP |
| 260014792 | 260010179 | null | 93 | Palliative (P) | 2016-12-27 | 2017-01-01 | POMB | N | N | 260020769 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260014793 | 260010180 | 1.72 | 76.8 | Palliative (P) | 2018-01-03 | 2018-01-11 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260020778 | CISPLATIN |
| 260014794 | 260010180 | 1.8 | 66.5 | Palliative (P) | 2017-04-25 | 2017-04-28 | EP | 02 | N | 260020778 | MAP |
| 260014795 | 260010182 | 1.76 | 86.8 | Palliative (P) | 2016-01-30 | 2016-01-30 | Cyclophosphamide PO +Vinorelbine IV | N | N | 260021633 | IFOSFAMIDE + PACLITAXEL |
| 260014796 | 260014822 | 1.8 | null | Curative (C) | 2019-08-14 | 2019-08-17 | IFOSFAMIDE + PACLITAXEL | 2 | N | 260021633 | BLEOMYCIN + VINCRISTINE |
| 260014797 | 260010190 | 1.54 | null | Neo-adjuvant (N) | 2015-12-09 | 2015-12-09 | CHOP - 21 days | 2 | N | 260022492 | BLEOMYCIN + VINCRISTINE |
| 260014798 | 260010192 | 1.73 | 83.5 | Curative (C) | null | 2016-04-13 | IPO | N | N | 260022515 | CISPLATIN |
| 260014799 | 260010195 | null | 69.1 | null | null | 2016-02-08 | POMB | null | null | 260023325 | GEMCITABINE + OXALIPLATIN |
| 260014800 | 260014824 | 1.81 | null | Curative (C) | 2016-04-27 | 2016-04-27 | BLEOMYCIN | N | N | 260023349 | BLEOMYCIN + CISPLATIN + VINCRISTINE |